PROCLAIM-CX-072: A Trial To Find Safe And Active Doses Of An ...
Từ khóa » Cx-072
-
CX-072 (pacmilimab), A Probody® PD-L1 Inhibitor, In Advanced Or ...
-
CX-072 (pacmilimab), A Probody PD-L1 Inhibitor, In Combination ...
-
CX-072 (pacmilimab), A Probody PD-L1 Inhibitor, In ... - PubMed
-
CX-072 (pacmilimab), A Probody ® PD-L1 Inhibitor, In Advanced Or ...
-
PROCLAIM-CX-072: Analysis Of Patients With Advanced Solid Tumors ...
-
Study Of PD-L1 Probody Therapeutic CX-072 In Combination With ...
-
Preliminary Results Of PROCLAIM-CX-072: The First-in-human, Dose ...
-
The First-in-human, Dose-finding PROCLAIM-CX-072 Trial To Assess ...
-
Pipeline - CytomX
-
CX-072 In Patients With Advanced/recurrent Solid Tumours Or ...
-
Probody Therapeutic Design Of 89 Zr-CX-072 Promotes ...
-
Analysis Of Patients With Advanced Solid Tumors Receiving Long-term ...
-
PROCLAIM-CX-072: A Phase 1/2 Trial To Find The Best Dose And Test ...